L’Oreal/Lancome’s claims for Genifique anti-aging products, among others, identify the products as drugs under food and drug law, according to FDA’s Sept. 7 warning letter. Agency cites claims suggesting the brand’s technology “boosts the activity of genes” and “improve[s] the condition around the stem cells” – language that is not altogether unique in today’s anti-aging cosmeceutical market.
Gene- and stem-cell-related performance claims for a bevy of products from L’Oreal S.A.’s Lancome brand make the products unapproved drugs under federal food and drug law, FDA asserts in a Sept. 7 warning to the company.
In the letter, the agency cites a slew of products and roughly a half-dozen claims appearing on Lancome’s U.S